Nalox™/Naloc™ is used to treat discolored and deformed nails resulting from fungal infection or psoriasis. The product was launched in the Nordic countries during autumn 2010. International launch is under way through partners in more than 50 countries.
Nalox/Naloc is a solution applied to the damaged nail. Nalox/Naloc is patented, and is based on proven compounds. Nalox/Naloc is available without prescription under the trademark Emtrix® in some countries and as Kerasal Nail® in USA. Its effect and safety have been documented in several clinical trials including more than 600 patients. Nalox/Naloc has a unique rapid mechanism of action and has demonstrated strong competitive results, including visible improvements already within 2-4 weeks. The Nalox™/ Naloc™ brands are owned by Meda AB.